Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Informing Patients about Biosimilar Medicines: The Role of European Patient Associations
Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 117-117
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

The acid sphingomyelinase/ceramide system in COVID-19
Johannes Kornhuber, Nicolas Hoertel, Erich Gulbins
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 307-314
Open Access | Times Cited: 96
Biosimilars in IBD: What Every Clinician Needs to Know
Anthony Angyal, Shubha Bhat
Current Gastroenterology Reports (2024) Vol. 26, Iss. 3, pp. 77-85
Closed Access | Times Cited: 8
Anti-inflammatory effect of lavender (Lavandula angustifolia Mill.) essential oil prepared during different plant phenophases on THP-1 macrophages
Edina Pandur, Alex Balatinácz, Giuseppe Micalizzi, et al.
BMC Complementary Medicine and Therapies (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 44
Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging
Liese Barbier, Allary Mbuaki, Steven Simoens, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 27
Cutaneous pain in disorders affecting peripheral nerves
Cheryl L. Stucky, Alexander R. Mikesell
Neuroscience Letters (2021) Vol. 765, pp. 136233-136233
Open Access | Times Cited: 31
Oncology biosimilars: New developments and future directions
Rinda Devi Bachu, Mariam Sami Abou-Dahech, Swapnaa Balaji, et al.
Cancer Reports (2022) Vol. 5, Iss. 11
Open Access | Times Cited: 22
Understanding Community Pharmacists’ Knowledge, Attitudes, and Practices Regarding Biosimilar Drugs: A Cross‐Sectional Survey
Anan S. Jarab, Walid Al‐Qerem, Karem H. Alzoubi, et al.
International Journal of Clinical Practice (2025) Vol. 2025, Iss. 1
Open Access
Awareness and Knowledge of Biosimilars Among Rheumatologists and Patients
Muhammad Shiraz Niaz, S M Syed Mohamed Suhail, Usama Mahmood
Journal of Health and Rehabilitation Research (2025) Vol. 5, Iss. 1, pp. 1-7
Closed Access
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease
Gionata Fiorino, Ashwin N. Ananthakrishnan, Russell D. Cohen, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1561-1561
Open Access
Switching from Adalimumab Reference Product to and Among Adalimumab Biosimilars Outside the USA: Insights for US Clinicians
John Tesser, Aline Charabaty, Adelaide A. Hebert
BioDrugs (2025)
Open Access
Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region
Khalid A. Alnaqbi, Nasra Al Adhoubi, Sara Al Dallal, et al.
BioDrugs (2024) Vol. 38, Iss. 3, pp. 449-463
Open Access | Times Cited: 3
Policy measures and instruments used in European countries to increase biosimilar uptake: a systematic review
Sara Machado, Agostinho Cruz, Pedro Lopes Ferreira, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 3
Enhanced reduction of polymicrobial biofilms on the orthodontic brackets and enamel surface remineralization using zeolite-zinc oxide nanoparticles-based antimicrobial photodynamic therapy
Maryam Pourhajibagher, Abbas Bahador
BMC Microbiology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 20
Updating the use of biochemical biomarkers in fish for the evaluation of alterations produced by pharmaceutical products
Sara E. Gallego Ríos, Gustavo A. Peñuela, Emma Martínez-López
Environmental Toxicology and Pharmacology (2021) Vol. 88, pp. 103756-103756
Closed Access | Times Cited: 20
Biased and allosteric modulation of bone cell-expressing G protein-coupled receptors as a novel approach to osteoporosis therapy
Alexander Kalinkovich, Gregory Livshits
Pharmacological Research (2021) Vol. 171, pp. 105794-105794
Closed Access | Times Cited: 19
Endophytic fungi: A treasure trove of novel anticancer compounds
Jignesh Prajapati, Dweipayan Goswami, Rakesh Rawal
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100050-100050
Open Access | Times Cited: 19
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
Yannick Vandenplas, Liese Barbier, Steven Simoens, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 13
Biosimilars in the Era of Artificial Intelligence—International Regulations and the Use in Oncological Treatments
Tomás Gabriel Bas, Vannessa Duarte
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 925-925
Open Access | Times Cited: 2
Bioactivities of Salvia nemorosa L. inflorescences are influenced by the extraction solvents
Marija Ivanov, Jelena Božunović, Uroš Gašić, et al.
Industrial Crops and Products (2021) Vol. 175, pp. 114260-114260
Closed Access | Times Cited: 17
Barriers to Biosimilar Prescribing Incentives in the Context of Clinical Governance in Spain
Félix Lobo, Isabel Río-Álvarez
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 283-283
Open Access | Times Cited: 16
Prescribed aggression of fishes: Pharmaceuticals modify aggression in environmentally relevant concentrations
Pavla Hubená, Pavel Horký, Roman Grabic, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 227, pp. 112944-112944
Open Access | Times Cited: 16
Moving forward: Implementing health psychology research to improve patient acceptance of biosimilars
Chiara Gasteiger, Keith J. Petrie
Research in Social and Administrative Pharmacy (2022) Vol. 18, Iss. 10, pp. 3860-3863
Closed Access | Times Cited: 11
Why purchase generic medicine? A theory of planned behavior perspective
A. Christina Josephine Malathi, K. Mohamed Jasim
Global Business and Organizational Excellence (2023) Vol. 43, Iss. 2, pp. 122-137
Closed Access | Times Cited: 6
Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey
Yang Hu, Zaiwei Song, Dan Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies
Liselotte Fierens, Claire Liefferinckx, Eveline Hoefkens, et al.
Journal of Crohn s and Colitis (2022) Vol. 16, Iss. 7, pp. 1059-1069
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top